A subsidiary of Bayer AG, the Germany-based pharmaceutical company, has filed suit in federal court in Wilmington against Glenmark Generics, an international generic-drug manufacturer, seeking to stop the Mumbai, India-based company from selling a generic form of a medication used to treat a skin disorder.
Font Size: 
Bayer Sues in U.S. to Stop India Generic-Drug Company
Delaware Business Court Insider
March 20, 2013
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.
